Alpha 1 Global

Our mission is to develop a collaborative global network of Alpha-1 patient leaders, physicians, and researchers, to increase awareness, detection, and access to care for Alphas around the world.


Grifols Update Regarding COVID-19

As the situation with the novel coronavirus rapidly evolves, we wanted to inform you that Grifols is taking measures in line with recommendations from the …

Read More

European Lung Foundation Offers Grants for Healthy Lungs for Life Events

In 2020, the European Lung Foundation (ELF) will open two rounds of grants applications. Each round will offer five grants of €1,000 to the applicants …

Read More

2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies

Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus (2019-nCoV) was first identified by …

Read More

Alpha-1 Global Reveals 2020 Global Hub Centers

Alpha-1 Global is proud to announce that three Alpha-1 patient organisations have been selected as Alpha-1 Global Hub Centers. The Alpha-1 Foundation Ireland, Fundación Argentina …

Read More

Grifols’s Prolastina Approved for Use in Denmark

The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols has received approval for reimbursement by the Danish Medicines Council for Prolastina, a …

Read More

Danish Medicines Council Grants Approval for CSL Behring’s Respreeza as Standard Treatment for Severe Alpha-1 Antitrypsin Deficiency Patients

HATTERSHEIM AM MAIN, Germany, Jan. 24, 2020 – Global biopharmaceutical company CSL Behring announced that the Danish Medicines Council has published its final decision regarding …

Read More

European Lung Foundation Conducts Alpha-1 Survey to Establish Future Research Priorities

The European Lung Foundation (ELF) is asking members of the Alpha-1 community for their help in identifying the challenges of care, treatment and living with …

Read More

Alpha-1 Global Announces Launch of Alpha-1 Global Hub Centers

Alpha-1 Global is launching a program called the Alpha-1 Global Hub Centers. The goal of the program is to create 5-6 centers globally that will …

Read More

CSL Behring Announces Grant for EU Advocacy Development

Dear EU Alpha-1 Global Partners: We are pleased to provide you information regarding CSL Behring’s announcement for Local Empowerment for Advocacy Development (LEAD) Grants available …

Read More

CSL Behring announcement on their product Zemaira

Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin …

Read More

Alpha-1 Around The Globe

Click on the country flags below to learn more about country specific contact and general information, access to care, and available resources

Join Our Newsletter

Subscribe to stay in touch with the latest in Alpha-1 Global